Concepedia

Mario Abdelmessih

MA

Statistics

Publications

3

Citations

51

H-Index

3

Active since

2021

Affiliations

Pfizer (United States)(Current)

Mario Abdelmessih is an author at Pfizer (United States) specializing in analytical ultracentrifugation, molecular modeling, and drug discovery.

Top concepts

Publications per year

2021–2024

3

Publications

3

A Comparison of Two Stability Proteomics Methods for Drug Target Identification in OnePot 2D Format

Yingrong Xu, Graham M. West, Mario Abdelmessih et al. · ACS Chemical Biology · 2021 · 23 citations

, , +20

Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators

Thomas A. Chappie, Mario Abdelmessih, Claude Ambroise et al. · ACS Medicinal Chemistry Letters · 2022 · 16 citations · Full text

UPF1 regulates mRNA stability by sensing poorly translated coding sequences

Damir Musaev, Mario Abdelmessih, Charles E. Vejnar et al. · Cell Reports · 2024 · 12 citations · Full text

1–3 of 3